Abstract:
BACKGROUND:Erlotinib is an epidermal growth factor receptor (EGFR)-targeting tyrosine kinase inhibitor approved for treatment of non-small cell lung cancer. The wide inter-individual pharmacokinetic (PK) variability of erlotinib may impact treatment outcome and/or toxicity. Recent in vivo studies reported a nonlinear uptake transport of erlotinib into the liver, suggesting carrier-mediated system(s) to mediate its hepatobiliary clearance. Erlotinib has been identified in vitro as a substrate of organic anion-transporting polypeptide (OATP) transporters which expression does not restrict to hepatocytes and may impact the tissue uptake of erlotinib in vivo. RESULTS:The impact of rifampicin (40 mg/kg), a potent OATP inhibitor, on the liver uptake and exposure to tissues of 11C-erlotinib was investigated in rats (4 animals per group) using positron emission tomography (PET) imaging. Tissue pharmacokinetics (PK) and corresponding exposure (area under the curve, AUC) were assessed in the liver, kidney cortex, abdominal aorta (blood pool) and the lungs. The plasma PK of parent 11C-erlotinib was also measured using arterial blood sampling to estimate the transfer rate constant (kuptake) of 11C-erlotinib from plasma into different tissues. PET images unveiled the predominant distribution of 11C-erlotinib-associated radioactivity to the liver, which gradually moved to the intestine, thus highlighting hepatobiliary clearance. 11C-erlotinib also accumulated in the kidney cortex. Rifampicin did not impact AUCaorta but reduced kuptake, liver (p < 0.001), causing a significant 27.3% decrease in liver exposure (p < 0.001). Moreover, a significant decrease in kuptake, kidney with a concomitant decrease in AUCkidney (- 30.4%, p < 0.001) were observed. Rifampicin neither affected kuptake, lung nor AUClung. CONCLUSIONS:Our results suggest that 11C-erlotinib is an in vivo substrate of rOATP transporters expressed in the liver and possibly of rifampicin-inhibitable transporter(s) in the kidneys. Decreased 11C-erlotinib uptake by elimination organs did not translate into changes in systemic exposure and exposure to the lungs, which are a target tissue for erlotinib therapy.
journal_name
EJNMMI Resjournal_title
EJNMMI researchauthors
Amor D,Goutal S,Marie S,Caillé F,Bauer M,Langer O,Auvity S,Tournier Ndoi
10.1186/s13550-018-0434-0subject
Has Abstractpub_date
2018-08-16 00:00:00pages
81issue
1issn
2191-219Xpii
10.1186/s13550-018-0434-0journal_volume
8pub_type
杂志文章相关文献
EJNMMI Research文献大全abstract:BACKGROUND:Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, but majority of patients develop disease recurrence following ADT. There is therefore an urgent need for early detection of treatment resistance. METHODS:Isogenic ...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-00728-9
更新日期:2020-11-25 00:00:00
abstract:BACKGROUND:Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpret...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-0596-4
更新日期:2020-02-28 00:00:00
abstract:BACKGROUND:Differentiated thyroid carcinoma (DTC) is the most common type of thyroid cancer. Treatment with surgery, radioactive iodine (RAI), and TSH suppression is effective in most patients. Five to 15% of patients become RAI refractory and need alternative therapy; however, treatment options are limited. 68Ga-PSMA ...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-0610-x
更新日期:2020-03-06 00:00:00
abstract:BACKGROUND:Macrophages represent a critical cell type in host defense, development and homeostasis. The ability to image non-invasively pro-inflammatory macrophage infiltrate into a transplanted organ may provide an additional tool for the monitoring of the immune response of the recipient against the donor graft. We t...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-015-0146-7
更新日期:2015-12-01 00:00:00
abstract:PURPOSE:Pathological complete response to the neoadjuvant therapy (NAT) for triple negative breast cancer (TNBC) is predictive of prolonged patient survival. Methods for early evaluation of NAT efficiency are still needed, in order to rapidly adjust the therapeutic strategy in case of initial non-response. One option f...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-019-0587-5
更新日期:2020-01-06 00:00:00
abstract::An amendment to this paper has been published and can be accessed via the original article. ...
journal_title:EJNMMI research
pub_type: 已发布勘误
doi:10.1186/s13550-020-00719-w
更新日期:2020-10-27 00:00:00
abstract:BACKGROUND:Off-target binding in the choroid plexus (CP) may cause spill-in of the tau PET tracer [18F] flortaucipir into the adjacent hippocampus region. The impact of this spill-in on hippocampal uptake was assessed using a novel partial volume correction method (PVC). METHODS:PVC was performed on 20 [18F] flortauci...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-018-0432-2
更新日期:2018-08-15 00:00:00
abstract:BACKGROUND:Assessment of liver function is critical in hepatocellular carcinoma (HCC) patient management. We evaluated parameters of [(99m)Tc] sulfur colloid (SC) SPECT/CT liver uptake for association with clinical measures of liver function and outcome in HCC patients. METHODS:Thirty patients with HCC and variable Ch...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-016-0212-9
更新日期:2016-12-01 00:00:00
abstract:BACKGROUND:Previously, we reported on the unexpected development of distant metastases in the subcutaneous rat pancreas CA20948 tumor model after 4.5 weeks of treatment with RAD001-only or in combination with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-DOTATATE) (Cancer Res. 73:12-8, 2013). Moreover, the combination th...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-014-0021-y
更新日期:2014-05-30 00:00:00
abstract:BACKGROUND:HEPES is a favorable buffer for 68Ga-complexations in radiochemical laboratories. The drawback of this buffer is its prescribed limit of 200 μg per recommended application volume in the final formulation. Currently, a TLC test according to the European Pharmacopoeia (Ph. Eur.) has to be performed for quantif...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-018-0449-6
更新日期:2018-10-23 00:00:00
abstract:BACKGROUND:Hypoxic tumours exhibit increased resistance to radiation, chemical, and immune therapies. 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) is a non-invasive, quantitative imaging technique used to evaluate the presence and spatial distribution of tumour hypoxia. To facilitate the use of FMI...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-016-0210-y
更新日期:2016-12-01 00:00:00
abstract:BACKGROUND:18F-FDG-PET imaging has emerged as a promising method in the diagnosis of chronic osteomyelitis commonly due to Staphylococcus aureus. The inaccuracy of 18 F-FDG-PET in the detection of periprosthetic joint infections may be related to the predominance of low-virulent S. epidermidis strains as the causative ...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-2-41
更新日期:2012-07-23 00:00:00
abstract:BACKGROUND:Glioblastoma, the most frequent and aggressive of all astrocytomas, presents a clear predominance in male humans, but the assessment of sexual differences in its tumourigenesis and growth has received little attention so far. In this study, we aim to identify gender-dependent surrogate markers in an animal m...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-014-0044-4
更新日期:2014-12-01 00:00:00
abstract:BACKGROUND:Hypoxia within solid tumors confers radiation resistance and a poorer prognosis. 124I-iodoazomycin galactopyranoside (124I-IAZGP) has shown promise as a hypoxia radiotracer in animal models. We performed a clinical study to evaluate the safety, biodistribution, and imaging characteristics of 124I-IAZGP in pa...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-3-42
更新日期:2013-06-03 00:00:00
abstract:BACKGROUND:Diacetyl-bis(N4-methylthiosemicarbazone), labeled with 64Cu (64Cu-ATSM) has been suggested as a promising tracer for imaging hypoxia. However, various controversial studies highlighted potential pitfalls that may disable its use as a selective hypoxic marker. They also highlighted that the results may be tum...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-019-0586-6
更新日期:2019-12-19 00:00:00
abstract:BACKGROUND:Two novel methods of image reconstruction, xSPECT Quant (xQ) and xSPECT Bone (xB), that use an ordered subset conjugate gradient minimizer (OSCGM) for SPECT/CT reconstruction have been proposed. The present study compares the performance characteristics of xQ, xB, and conventional Flash3D (F3D) reconstructio...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-00659-5
更新日期:2020-06-29 00:00:00
abstract:BACKGROUND:Fluorine-18 fluoroethoxybenzovesamicol ([18F]FEOBV) is a radioligand for the selective imaging of the vesicular acetylcholine transporter with positron emission tomography (PET). The current study demonstrates that pathological cortical cholinergic deafferentation can be quantified in vivo with [18F]FEOBV PE...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-3-70
更新日期:2013-10-09 00:00:00
abstract::Translocator protein (TSPO) is a biomarker for detecting neuroinflammation by PET. 11C-(R)-PK11195 has been used to image TSPO since the 1980s. Here, we compared the utility of four 11C-labeled ligands-(R)-PK11195, PBR28, DPA-713, and ER176-to quantify TSPO in healthy humans. For all of these ligands, BP ND (specific-...
journal_title:EJNMMI research
pub_type: 信件
doi:10.1186/s13550-017-0334-8
更新日期:2017-10-16 00:00:00
abstract:BACKGROUND:Noninvasive multimodality imaging is essential for preclinical evaluation of the biodistribution and pharmacokinetics of radionuclide therapy and for monitoring tumor response. Imaging with nonstandard positron-emission tomography [PET] isotopes such as 124I is promising in that context but requires accurate...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-2-7
更新日期:2012-02-13 00:00:00
abstract:BACKGROUND:Gastrin-releasing peptide receptor antagonists have promise in theranostics of several highly incident tumours, including prostate and breast. This study presents the first human dosimetry of 68Ga-NODAGA-MJ9 in the first five consecutive patients with recurrent prostate cancer included in a dual-tracer posit...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-018-0462-9
更新日期:2018-12-12 00:00:00
abstract:BACKGROUND:The biology of the vulnerable plaque includes increased inflammation and rapid growth of vasa vasorum, processes that are associated with enhanced vascular endothelial growth factor (VEGF)/ imaging receptors for VEGF (VEGFR) signaling and are accelerated in diabetes. This study was designed to test the hypot...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-014-0041-7
更新日期:2014-12-01 00:00:00
abstract:BACKGROUND:Quantification of cerebral blood flow (CBF) is important for the understanding of normal and pathologic brain physiology. Positron emission tomography (PET) with H215O (or C15O2) can quantify CBF and apply kinetic analyses, including autoradiography (ARG) and the basis function methods (BFM). These approache...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-3-41
更新日期:2013-05-23 00:00:00
abstract:BACKGROUND:We recently showed improved between-subject variability in our [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) experiments using a Michaelis-Menten transport model to calculate the metabolic tumor glucose uptake rate extrapolated to the hypothetical condition of glucose saturation: MRgl...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-2-35
更新日期:2012-06-27 00:00:00
abstract:BACKGROUND:In vivo determination of regional pulmonary blood flow (PBF) is a valuable tool for the evaluation of many lung diseases. In this study, the use of 68Ga-DOTA PET for the in vivo quantitative determination of regional PBF is proposed. This methodology was implemented and tested in healthy pigs and validated u...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-017-0259-2
更新日期:2017-12-01 00:00:00
abstract:UNLABELLED: BACKGROUND:In single-photon emission computed tomography (SPECT), attenuation of photon flux in tissue affects quantitative accuracy of reconstructed images. Attenuation maps derived from X-ray computed tomography (CT) can be employed for attenuation correction. The attenuation coefficients as well as regi...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/2191-219X-3-7
更新日期:2013-01-31 00:00:00
abstract:BACKGROUND:The molecular features of isocitrate dehydrogenase (IDH) mutation and chromosome 1p and 19q (1p/19q) codeletion status have pivotal role for differentiating gliomas and have been integrated in the World Health Organization (WHO) classification in 2016. Positron emission tomography (PET) with 3'-deoxy-3'-[18F...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-00633-1
更新日期:2020-05-07 00:00:00
abstract:PURPOSE:Chimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth, which is overexpressed in solid tumours, including prostate cancer (PCa). This st...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-00637-x
更新日期:2020-05-07 00:00:00
abstract:BACKGROUND:High expression of human epidermal growth factor receptor type 2 (HER2) represents an aggressive subtype of breast cancer. Anti-HER2 treatment requires a theragnostic approach wherein sufficiently high receptor expression in biopsy material is mandatory. Heterogeneity and discordance of HER2 expression betwe...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-0603-9
更新日期:2020-03-23 00:00:00
abstract:BACKGROUND:Given the increasing clinical use of PET/MRI, potential risks to patients from simultaneous exposure to ionising radiation and (electro)magnetic fields should be thoroughly investigated as a precaution. With this aim, the genotoxic potential of 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) and a strong static m...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-020-00625-1
更新日期:2020-04-28 00:00:00
abstract:BACKGROUND:Over the last decade, a few radioligands have been developed for PET imaging of brain 5-HT1B receptors. The 5-HT1B receptor is a G-protein-coupled receptor (GPCR) that exists in two different agonist affinity states. An agonist ligand is expected to be more sensitive towards competition from another agonist,...
journal_title:EJNMMI research
pub_type: 杂志文章
doi:10.1186/s13550-019-0570-1
更新日期:2019-11-21 00:00:00